Strength
.5 mg/mL
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832605405
Classification
Generic
Dosage Form
EMULSION
Route
OPHTHALMIC
Last Updated
4/22/2026
Active Ingredients
DIFLUPREDNATEApproval Type
Generic (ANDA)
FDA Application
ANDA218191On Market Since
2/21/2025
Related Drugs
Same classification
No related drugs found.